CN109293776B - Fipronil specific binding protein and application thereof - Google Patents
Fipronil specific binding protein and application thereof Download PDFInfo
- Publication number
- CN109293776B CN109293776B CN201811341754.8A CN201811341754A CN109293776B CN 109293776 B CN109293776 B CN 109293776B CN 201811341754 A CN201811341754 A CN 201811341754A CN 109293776 B CN109293776 B CN 109293776B
- Authority
- CN
- China
- Prior art keywords
- solution
- fipronil
- protein
- labeled
- hapten
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- ZOCSXAVNDGMNBV-UHFFFAOYSA-N 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound NC1=C(S(=O)C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl ZOCSXAVNDGMNBV-UHFFFAOYSA-N 0.000 title claims abstract description 127
- 239000005899 Fipronil Substances 0.000 title claims abstract description 124
- 229940013764 fipronil Drugs 0.000 title claims abstract description 124
- 102000014914 Carrier Proteins Human genes 0.000 title claims abstract description 14
- 108091008324 binding proteins Proteins 0.000 title abstract description 9
- 230000009870 specific binding Effects 0.000 title abstract description 9
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 33
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 28
- 239000000243 solution Substances 0.000 claims description 108
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 50
- 238000001514 detection method Methods 0.000 claims description 35
- 235000018102 proteins Nutrition 0.000 claims description 26
- 238000012360 testing method Methods 0.000 claims description 25
- 238000003756 stirring Methods 0.000 claims description 24
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 17
- 239000000020 Nitrocellulose Substances 0.000 claims description 17
- 239000012528 membrane Substances 0.000 claims description 17
- 229920001220 nitrocellulos Polymers 0.000 claims description 17
- 238000002965 ELISA Methods 0.000 claims description 15
- 239000002244 precipitate Substances 0.000 claims description 15
- 238000005406 washing Methods 0.000 claims description 15
- 239000007853 buffer solution Substances 0.000 claims description 14
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 108090000790 Enzymes Proteins 0.000 claims description 13
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 12
- 239000003085 diluting agent Substances 0.000 claims description 11
- 239000006228 supernatant Substances 0.000 claims description 11
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 10
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 10
- 229940098773 bovine serum albumin Drugs 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000010521 absorption reaction Methods 0.000 claims description 9
- 239000000427 antigen Substances 0.000 claims description 9
- 102000036639 antigens Human genes 0.000 claims description 9
- 108091007433 antigens Proteins 0.000 claims description 9
- 238000003908 quality control method Methods 0.000 claims description 9
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 8
- 238000007865 diluting Methods 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 239000005457 ice water Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 8
- 239000012460 protein solution Substances 0.000 claims description 8
- 239000012086 standard solution Substances 0.000 claims description 8
- 238000000502 dialysis Methods 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 6
- 239000012089 stop solution Substances 0.000 claims description 6
- 108010078791 Carrier Proteins Proteins 0.000 claims description 5
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 5
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 5
- 239000008055 phosphate buffer solution Substances 0.000 claims description 5
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 claims description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 4
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 238000011534 incubation Methods 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 229940014800 succinic anhydride Drugs 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- 229920000136 polysorbate Polymers 0.000 claims description 3
- 230000027455 binding Effects 0.000 claims description 2
- 230000000903 blocking effect Effects 0.000 claims description 2
- 239000005018 casein Substances 0.000 claims description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 2
- 235000021240 caseins Nutrition 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 abstract description 10
- 238000000034 method Methods 0.000 abstract description 6
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 description 10
- 239000010931 gold Substances 0.000 description 9
- 229910052737 gold Inorganic materials 0.000 description 9
- 235000013305 food Nutrition 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 6
- 239000008267 milk Substances 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- 229920000915 polyvinyl chloride Polymers 0.000 description 6
- 239000004800 polyvinyl chloride Substances 0.000 description 6
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- 239000005944 Chlorpyrifos Substances 0.000 description 2
- 239000005946 Cypermethrin Substances 0.000 description 2
- 102000005915 GABA Receptors Human genes 0.000 description 2
- 108010005551 GABA Receptors Proteins 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 239000005906 Imidacloprid Substances 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- SMLCYZYQFRTLCO-UWJYBYFXSA-N Tyr-Cys-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O SMLCYZYQFRTLCO-UWJYBYFXSA-N 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 229960005424 cypermethrin Drugs 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- DFBKLUNHFCTMDC-PICURKEMSA-N dieldrin Chemical compound C([C@H]1[C@H]2[C@@]3(Cl)C(Cl)=C([C@]([C@H]22)(Cl)C3(Cl)Cl)Cl)[C@H]2[C@@H]2[C@H]1O2 DFBKLUNHFCTMDC-PICURKEMSA-N 0.000 description 2
- 229950006824 dieldrin Drugs 0.000 description 2
- NGPMUTDCEIKKFM-UHFFFAOYSA-N dieldrin Natural products CC1=C(Cl)C2(Cl)C3C4CC(C5OC45)C3C1(Cl)C2(Cl)Cl NGPMUTDCEIKKFM-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- DFBKLUNHFCTMDC-GKRDHZSOSA-N endrin Chemical compound C([C@@H]1[C@H]2[C@@]3(Cl)C(Cl)=C([C@]([C@H]22)(Cl)C3(Cl)Cl)Cl)[C@@H]2[C@H]2[C@@H]1O2 DFBKLUNHFCTMDC-GKRDHZSOSA-N 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 2
- 229940056881 imidacloprid Drugs 0.000 description 2
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000012898 sample dilution Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- OEDUIFSDODUDRK-UHFFFAOYSA-N 5-phenyl-1h-pyrazole Chemical compound N1N=CC=C1C1=CC=CC=C1 OEDUIFSDODUDRK-UHFFFAOYSA-N 0.000 description 1
- RLMISHABBKUNFO-WHFBIAKZSA-N Ala-Ala-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 1
- PJNSIUPOXFBHDM-GUBZILKMSA-N Ala-Arg-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O PJNSIUPOXFBHDM-GUBZILKMSA-N 0.000 description 1
- NFDVJAKFMXHJEQ-HERUPUMHSA-N Ala-Asp-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N NFDVJAKFMXHJEQ-HERUPUMHSA-N 0.000 description 1
- SMCGQGDVTPFXKB-XPUUQOCRSA-N Ala-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N SMCGQGDVTPFXKB-XPUUQOCRSA-N 0.000 description 1
- RTZCUEHYUQZIDE-WHFBIAKZSA-N Ala-Ser-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RTZCUEHYUQZIDE-WHFBIAKZSA-N 0.000 description 1
- OMCKWYSDUQBYCN-FXQIFTODSA-N Ala-Ser-Met Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(O)=O OMCKWYSDUQBYCN-FXQIFTODSA-N 0.000 description 1
- KTXKIYXZQFWJKB-VZFHVOOUSA-N Ala-Thr-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O KTXKIYXZQFWJKB-VZFHVOOUSA-N 0.000 description 1
- XPSGESXVBSQZPL-SRVKXCTJSA-N Arg-Arg-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O XPSGESXVBSQZPL-SRVKXCTJSA-N 0.000 description 1
- WVNFNPGXYADPPO-BQBZGAKWSA-N Arg-Gly-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O WVNFNPGXYADPPO-BQBZGAKWSA-N 0.000 description 1
- FSNVAJOPUDVQAR-AVGNSLFASA-N Arg-Lys-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FSNVAJOPUDVQAR-AVGNSLFASA-N 0.000 description 1
- UVTGNSWSRSCPLP-UHFFFAOYSA-N Arg-Tyr Natural products NC(CCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(=O)O UVTGNSWSRSCPLP-UHFFFAOYSA-N 0.000 description 1
- VYZBPPBKFCHCIS-WPRPVWTQSA-N Arg-Val-Gly Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N VYZBPPBKFCHCIS-WPRPVWTQSA-N 0.000 description 1
- VKCOHFFSTKCXEQ-OLHMAJIHSA-N Asn-Asn-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VKCOHFFSTKCXEQ-OLHMAJIHSA-N 0.000 description 1
- WQSCVMQDZYTFQU-FXQIFTODSA-N Asn-Cys-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WQSCVMQDZYTFQU-FXQIFTODSA-N 0.000 description 1
- AECPDLSSUMDUAA-ZKWXMUAHSA-N Asn-Val-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)N)N AECPDLSSUMDUAA-ZKWXMUAHSA-N 0.000 description 1
- MYLZFUMPZCPJCJ-NHCYSSNCSA-N Asp-Lys-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O MYLZFUMPZCPJCJ-NHCYSSNCSA-N 0.000 description 1
- JGLWFWXGOINXEA-YDHLFZDLSA-N Asp-Val-Tyr Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 JGLWFWXGOINXEA-YDHLFZDLSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 108010062745 Chloride Channels Proteins 0.000 description 1
- 102000011045 Chloride Channels Human genes 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- NDNZRWUDUMTITL-FXQIFTODSA-N Cys-Ser-Val Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O NDNZRWUDUMTITL-FXQIFTODSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- LCNXZQROPKFGQK-WHFBIAKZSA-N Gly-Asp-Ser Chemical compound NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O LCNXZQROPKFGQK-WHFBIAKZSA-N 0.000 description 1
- ZLCLYFGMKFCDCN-XPUUQOCRSA-N Gly-Ser-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)CN)C(O)=O ZLCLYFGMKFCDCN-XPUUQOCRSA-N 0.000 description 1
- TVTZEOHWHUVYCG-KYNKHSRBSA-N Gly-Thr-Thr Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O TVTZEOHWHUVYCG-KYNKHSRBSA-N 0.000 description 1
- YDIDLLVFCYSXNY-RCOVLWMOSA-N Gly-Val-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN YDIDLLVFCYSXNY-RCOVLWMOSA-N 0.000 description 1
- HRGGKHFHRSFSDE-CIUDSAMLSA-N His-Asn-Ser Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N HRGGKHFHRSFSDE-CIUDSAMLSA-N 0.000 description 1
- BZKDJRSZWLPJNI-SRVKXCTJSA-N His-His-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O BZKDJRSZWLPJNI-SRVKXCTJSA-N 0.000 description 1
- CSTDQOOBZBAJKE-BWAGICSOSA-N His-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CN=CN2)N)O CSTDQOOBZBAJKE-BWAGICSOSA-N 0.000 description 1
- RVOMPSJXSRPFJT-DCAQKATOSA-N Lys-Ala-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O RVOMPSJXSRPFJT-DCAQKATOSA-N 0.000 description 1
- GAOJCVKPIGHTGO-UWVGGRQHSA-N Lys-Arg-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O GAOJCVKPIGHTGO-UWVGGRQHSA-N 0.000 description 1
- RYOLKFYZBHMYFW-WDSOQIARSA-N Lys-Trp-Arg Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 RYOLKFYZBHMYFW-WDSOQIARSA-N 0.000 description 1
- OHXUUQDOBQKSNB-AVGNSLFASA-N Lys-Val-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O OHXUUQDOBQKSNB-AVGNSLFASA-N 0.000 description 1
- VKCPHIOZDWUFSW-ONGXEEELSA-N Lys-Val-Gly Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN VKCPHIOZDWUFSW-ONGXEEELSA-N 0.000 description 1
- FYRUJIJAUPHUNB-IUCAKERBSA-N Met-Gly-Arg Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCNC(N)=N FYRUJIJAUPHUNB-IUCAKERBSA-N 0.000 description 1
- LRALLISKBZNSKN-BQBZGAKWSA-N Met-Gly-Ser Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LRALLISKBZNSKN-BQBZGAKWSA-N 0.000 description 1
- LXCSZPUQKMTXNW-BQBZGAKWSA-N Met-Ser-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O LXCSZPUQKMTXNW-BQBZGAKWSA-N 0.000 description 1
- QYIGOFGUOVTAHK-ZJDVBMNYSA-N Met-Thr-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QYIGOFGUOVTAHK-ZJDVBMNYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 241001674048 Phthiraptera Species 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 239000005869 Pyraclostrobin Substances 0.000 description 1
- OYEDZGNMSBZCIM-XGEHTFHBSA-N Ser-Arg-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OYEDZGNMSBZCIM-XGEHTFHBSA-N 0.000 description 1
- MOVJSUIKUNCVMG-ZLUOBGJFSA-N Ser-Cys-Ser Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O)N)O MOVJSUIKUNCVMG-ZLUOBGJFSA-N 0.000 description 1
- CXBFHZLODKPIJY-AAEUAGOBSA-N Ser-Gly-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CO)N CXBFHZLODKPIJY-AAEUAGOBSA-N 0.000 description 1
- XXXAXOWMBOKTRN-XPUUQOCRSA-N Ser-Gly-Val Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXXAXOWMBOKTRN-XPUUQOCRSA-N 0.000 description 1
- IOVBCLGAJJXOHK-SRVKXCTJSA-N Ser-His-His Chemical compound C([C@H](NC(=O)[C@H](CO)N)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 IOVBCLGAJJXOHK-SRVKXCTJSA-N 0.000 description 1
- HZNFKPJCGZXKIC-DCAQKATOSA-N Ser-His-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CO)N HZNFKPJCGZXKIC-DCAQKATOSA-N 0.000 description 1
- VFWQQZMRKFOGLE-ZLUOBGJFSA-N Ser-Ser-Cys Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N)O VFWQQZMRKFOGLE-ZLUOBGJFSA-N 0.000 description 1
- UYLKOSODXYSWMQ-XGEHTFHBSA-N Ser-Thr-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CO)N)O UYLKOSODXYSWMQ-XGEHTFHBSA-N 0.000 description 1
- JGUWRQWULDWNCM-FXQIFTODSA-N Ser-Val-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O JGUWRQWULDWNCM-FXQIFTODSA-N 0.000 description 1
- ZUUDNCOCILSYAM-KKHAAJSZSA-N Thr-Asp-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O ZUUDNCOCILSYAM-KKHAAJSZSA-N 0.000 description 1
- XPNSAQMEAVSQRD-FBCQKBJTSA-N Thr-Gly-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(=O)NCC(O)=O XPNSAQMEAVSQRD-FBCQKBJTSA-N 0.000 description 1
- IVDFVBVIVLJJHR-LKXGYXEUSA-N Thr-Ser-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O IVDFVBVIVLJJHR-LKXGYXEUSA-N 0.000 description 1
- IQPWNQRRAJHOKV-KATARQTJSA-N Thr-Ser-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN IQPWNQRRAJHOKV-KATARQTJSA-N 0.000 description 1
- CSZFFQBUTMGHAH-UAXMHLISSA-N Thr-Thr-Trp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N)O CSZFFQBUTMGHAH-UAXMHLISSA-N 0.000 description 1
- CURFABYITJVKEW-QTKMDUPCSA-N Thr-Val-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O CURFABYITJVKEW-QTKMDUPCSA-N 0.000 description 1
- YHRCLOURJWJABF-WDSOQIARSA-N Trp-His-Arg Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CN=CN3)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N YHRCLOURJWJABF-WDSOQIARSA-N 0.000 description 1
- NWQCKAPDGQMZQN-IHPCNDPISA-N Trp-Lys-Leu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O NWQCKAPDGQMZQN-IHPCNDPISA-N 0.000 description 1
- BABINGWMZBWXIX-BPUTZDHNSA-N Trp-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N BABINGWMZBWXIX-BPUTZDHNSA-N 0.000 description 1
- NOXKHHXSHQFSGJ-FQPOAREZSA-N Tyr-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NOXKHHXSHQFSGJ-FQPOAREZSA-N 0.000 description 1
- GAYLGYUVTDMLKC-UWJYBYFXSA-N Tyr-Asp-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 GAYLGYUVTDMLKC-UWJYBYFXSA-N 0.000 description 1
- COYSIHFOCOMGCF-UHFFFAOYSA-N Val-Arg-Gly Natural products CC(C)C(N)C(=O)NC(C(=O)NCC(O)=O)CCCN=C(N)N COYSIHFOCOMGCF-UHFFFAOYSA-N 0.000 description 1
- XJFXZQKJQGYFMM-GUBZILKMSA-N Val-Cys-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)O)N XJFXZQKJQGYFMM-GUBZILKMSA-N 0.000 description 1
- HWNYVQMOLCYHEA-IHRRRGAJSA-N Val-Ser-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N HWNYVQMOLCYHEA-IHRRRGAJSA-N 0.000 description 1
- NZYNRRGJJVSSTJ-GUBZILKMSA-N Val-Ser-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O NZYNRRGJJVSSTJ-GUBZILKMSA-N 0.000 description 1
- OFTXTCGQJXTNQS-XGEHTFHBSA-N Val-Thr-Ser Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C(C)C)N)O OFTXTCGQJXTNQS-XGEHTFHBSA-N 0.000 description 1
- LLJLBRRXKZTTRD-GUBZILKMSA-N Val-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)O)N LLJLBRRXKZTTRD-GUBZILKMSA-N 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 108010086434 alanyl-seryl-glycine Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 108010068380 arginylarginine Proteins 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- KAATUXNTWXVJKI-UHFFFAOYSA-N cypermethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-UHFFFAOYSA-N 0.000 description 1
- 108010069495 cysteinyltyrosine Proteins 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
- 108010015792 glycyllysine Proteins 0.000 description 1
- 108010087823 glycyltyrosine Proteins 0.000 description 1
- 108010028295 histidylhistidine Proteins 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 108010016686 methionyl-alanyl-serine Proteins 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- HZRSNVGNWUDEFX-UHFFFAOYSA-N pyraclostrobin Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=NN(C=2C=CC(Cl)=CC=2)C=C1 HZRSNVGNWUDEFX-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 108010072986 threonyl-seryl-lysine Proteins 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
Abstract
The embodiment of the invention discloses fipronil specific binding protein and application thereof, wherein the amino acid sequence of the protein is shown as SEQ ID NO.1, or the sequence is replaced, deleted or added with one or more amino acids to form an amino acid sequence with the same function. The protein is easy to prepare, can be specifically combined with fipronil, and has high specificity and sensitivity; in addition, the method can be used for detecting fipronil in a sample.
Description
Technical Field
The invention relates to the technical field of fipronil detection, in particular to fipronil specific binding protein and application thereof.
Background
Fipronil (also known as Fipronil, CAS number 120068-37-3) is a phenylpyrazole pesticide with broad insecticidal spectrum, mainly has stomach poisoning effect on pests, has contact killing and certain systemic action, and has the action mechanism that the Fipronil is combined with gamma-aminobutyric acid receptors of insects to block chloride ion channels controlled by gamma-aminobutyric acid and prevent chloride metabolism from interfering with the central nervous system, so that the nerve and muscle of the insects are excessively excited to death. Fipronil is also used to kill fleas and lice on cats and dogs.
The daily allowable intake (ADI) of fipronil recommended by the European food safety agency in 2006 is 0.0002mg/kg, and the ADI recommended by China in the national food safety Standard-maximum limit of pesticide residue in food (GB 2763-2016) is also 0.0002 mg/kg. In 50 kinds of pesticide maximum residual limit (survey draft) such as pyraclostrobin in national standard food for food safety issued in 2016 in 11 months in China, the maximum residual limit of fipronil in poultry meat is regulated to be 0.01mg/kg, and the maximum residual limit in eggs is 0.02 mg/kg. In 2017, in 9 months, the Ministry of agriculture in China issued No. 2583 bulletin, which prohibits fipronil and related preparations from being used for food animals.
At present, fipronil detection mainly takes an instrument analysis method as a main method, and fipronil in various samples is quantitatively detected based on a high performance liquid chromatography or liquid chromatography-mass spectrometry combined technology, so that the instrument is expensive, complicated to operate and incapable of being applied to field detection; the immunological detection method has the defects of long antibody preparation period, high screening difficulty, complex process, high cost and the like.
Disclosure of Invention
The first purpose of the embodiments of the present invention is to provide a fipronil specific binding protein, which is easy to prepare, can be specifically bound with fipronil, and has high specificity and sensitivity.
The second purpose of the embodiment of the invention is to provide an application of fipronil specific binding protein in a fipronil detection kit and a colloidal gold detection test strip, wherein the application is simple to operate and can be used for quickly and accurately detecting fipronil in a sample; in addition, the field detection of the sample is realized.
In order to achieve the above purpose, the embodiment of the present invention provides a protein specifically binding to fipronil, wherein the amino acid sequence of the protein is shown as SEQ ID No.1, or the sequence is formed by replacing, deleting or adding one or more amino acids to form an amino acid sequence with equivalent functions.
The preparation method of the protein is not strictly limited in the invention, and for example, the protein can be obtained by an artificial synthesis method, specifically, a corresponding gene sequence obtained by bioinformatics screening is shown as SEQ ID No.2, and is obtained by expressing the gene sequence.
The other aspect of the embodiment of the invention provides a fipronil detection kit, which comprises a kit body, an ELISA plate and a reagent, wherein the ELISA plate and the reagent are detachably arranged in the kit body, and each hole of the ELISA plate is coated with the protein; the reagent comprises enzyme-labeled fipronil, fipronil standard solution, developing solution, stop solution, washing solution and sample diluent.
Preferably, the ELISA plate is prepared by the following steps:
diluting the protein to 0.5-2 mu g/ml by adopting a carbonate buffer solution, adding 50-100 mu L of the protein diluent into each hole of an enzyme label plate, and incubating overnight at the temperature of 3-5 ℃; spin-drying the protein diluent, washing the plate for 2-4 times by using a phosphate Tween buffer solution, adding a confining liquid into the ELISA plate, incubating for 1.5-2.5h at 35-39 ℃, and spin-drying the confining liquid to obtain the ELISA plate;
wherein the pH value of the carbonate buffer solution is 9.4-10; preferably 9.6; the blocking solution is 0.01M pH7.2PBS solution containing 0.05% bovine serum albumin and 5% casein or 0.01M pH7.2PBS solution containing 1% gelatin.
Preferably, the enzyme-labeled fipronil is a horseradish peroxidase-labeled fipronil hapten. More preferably, the horseradish peroxidase-labeled fipronil hapten is prepared by the following steps:
(1) dissolving fipronil hapten in N, N-dimethylformamide solution, and diluting by adopting PBS buffer solution; preferably, the mass-volume ratio of the fipronil hapten to the N, N-dimethylformamide solution is (25-28) to 1 mg/ml; the concentration of the fipronil hapten diluted by PBS buffer solution is 3.1-3.5 mg/ml;
(2) adding horseradish peroxidase into the fipronil hapten solution, and fully dissolving; preferably, the mass ratio of the addition amount of the horseradish peroxidase to the fipronil hapten is 25: 12-14;
(3) adding a glutaraldehyde solution into the dissolved mixed solution, stirring, and then dropwise adding saturated ammonium sulfate with the same volume under the stirring condition for reaction; preferably, the mass concentration of the glutaraldehyde solution is 4% -5%, and the volume ratio of the addition amount of the glutaraldehyde solution to the fipronil hapten solution is 150: 6-10; the stirring temperature is room temperature, and the stirring time is 3.5-4.5 h; the reaction temperature is 3-5 ℃, and the reaction time is 0.8-1.2 h;
(4) centrifuging the reacted solution, collecting precipitate, cleaning, dissolving the precipitate in PBS solution, dialyzing by using a dialysis bag, centrifuging, and collecting supernatant to obtain the enzyme-labeled fipronil hapten; preferably the cleaning solution is a semi-saturated ammonium sulfate solution; the pH of the PBS solution is 7.4, and the concentration is 0.15 mol/L; the molecular weight of the dialysis bag is 10 KDa; the centrifugal speed is 3000 plus 15000r/min, and the centrifugal time is 25-35 min.
Preferably, the fipronil standard solution comprises fipronil solutions with concentrations of 0ng/ml, 0.1ng/ml, 0.3ng/ml, 0.9ng/ml, 2.7ng/ml and 8.1ng/ml respectively.
Preferably, the color developing solution is a single-component TMB color developing solution.
Preferably, the stop solution is a sulfuric acid solution with the concentration of 0.2-2M.
Preferably, the washing solution is 0.01M PBS solution with pH7.2 containing 0.5% Tween-20.
Preferably, the sample dilution is 0.1M PBS solution at pH 7.2.
The embodiment of the invention also provides a fipronil colloidal gold test strip, which comprises a PVC (polyvinyl chloride) back plate, a nitrocellulose membrane, a gold-labeled pad, a sample pad and a water absorption pad, wherein the gold-labeled pad is sprayed with the protein labeled by colloidal gold; the nitrocellulose membrane is provided with a detection line and a quality control line, the detection line is coated with a fipronil antigen, and the quality control line is coated with a mouse anti-His tag antibody.
Preferably, the nitrocellulose membrane in the test strip is adhered to a PVC back plate; a gold label pad is adhered to the detection line (T line) end of the nitrocellulose membrane, the distance between the upper end of the gold label pad and the T line is 4-10mm, and the distance is 1-3mm coincident with the nitrocellulose membrane; the sample pad is stuck on the gold label pad and is superposed with the gold label pad by 1-3 mm; the end of the quality control line (line C) of the nitrocellulose membrane is adhered with a water absorption pad, the distance between the water absorption pad and the line C is 4-10mm, and the water absorption pad and the nitrocellulose membrane are superposed by 1-3 mm.
In the invention, the source of the colloidal gold is not strictly limited, and the colloidal gold can be purchased from the market and can also be prepared by a sodium citrate reduction method; specifically, 0.01% chloroauric acid aqueous solution is heated to boiling, 1% trisodium citrate aqueous solution is added under the condition of continuous stirring, the solution is continuously stirred and heated until the solution is in a bright wine red color, the solution is cooled at room temperature, and then deionized water is used for recovering the solution to the original volume to obtain colloidal gold particles with the particle size of 30-40 nm; wherein the volume ratio of the sodium citrate aqueous solution to the chloroauric acid aqueous solution is 1.5-2.5%.
Preferably, the colloidal gold-labeled protein is prepared by the following steps:
(1) adding K to the colloidal gold solution2CO3A solution; preferably, the mass concentration of the colloidal gold solution is 1% -2%; the concentration of the potassium carbonate solution is 0.08-0.12 mol/L; the volume ratio of the colloidal gold solution to the potassium carbonate solution is 500: 1-10;
(2) adding the protein solution into the colloidal gold solution for incubation; then, adding bovine serum albumin into the incubated solution, uniformly mixing, centrifuging and collecting precipitates; preferably, the concentration of the protein solution is 0.03-0.05mg/ml, and the volume ratio of the addition amount to the colloidal gold solution is 500: 5-9; the incubation temperature is room temperature, and the incubation time is 18-22 min; the concentration of the bovine serum albumin in the solution added with the bovine serum albumin is 0.2 percent g/ml; the centrifugal speed is 9000-12000r/min, and the centrifugal time is 35-45 min;
(3) re-dissolving the precipitate by using a phosphate buffer solution to obtain the protein marked by the colloidal gold particles; preferably, the phosphate buffer is a 0.02M phosphate buffer containing 1% sucrose, 1% trehalose, 2% BSA, 0.02% sodium azide.
Preferably, the preparation method of the fipronil antigen comprises the following steps:
(1) mixing fipronil, succinic anhydride and anhydrous pyridine, and stirring; preferably, the mass ratio of the fipronil to the succinic anhydride is (34-36) to 16; the mass volume ratio of the fipronil to the anhydrous pyridine is (1.7-1.8) to 40 g/ml;
(2) heating and refluxing the mixture, adding ice water, adjusting the pH value, and storing overnight; preferably, the heating reflux time is 3.5-4.5h, and is used for removing pyridine; the volume ratio of the addition amount of the ice water to the anhydrous pyridine is 3: 3-5; adjusting the pH to 2.5-3.5; the preservation temperature is 3-5 ℃;
(3) filtering the solution after the overnight, washing with ice water, filtering again, repeating the washing with ice water, and filtering again for 2-4 times to obtain fipronil hapten;
(4) dissolving fipronil hapten in anhydrous N, N '-dimethylformamide, then adding N, N' -dicyclohexylcarbodiimide into the fipronil hapten solution, stirring, adding N-hydroxysuccinimide into the fipronil hapten solution after stirring, and carrying out a light-resistant reaction at room temperature under the stirring condition; preferably, the mass-volume ratio of the fipronil hapten to the anhydrous N, N' -dimethylformamide is (80-81) to 3 mg/ml; the mass ratio of fipronil hapten to N, N' -dicyclohexylcarbodiimide to N-hydroxysuccinimide is (80-81) to 31: 20; stirring for 9-11 min; reacting for 7-9h in a dark place;
(5) centrifuging the solution after the reaction is finished, collecting supernatant, dropwise adding the supernatant into a carrier protein solution prepared by buffer solution, and stirring overnight; preferably, the carrier protein is ovalbumin or bovine serum albumin; the buffer solution is 0.1mol/l phosphate buffer solution with pH of 8.0; the concentration of the carrier protein solution is 9-11 mg/ml; the volume ratio of the carrier protein solution to the anhydrous N, N' -dimethylformamide in the step (4) is 5: 2-4;
(6) dialyzing and purifying the overnight product by using a dialysis bag to obtain fipronil antigen; preferably, the dialysis bag has a molecular weight cut-off of 10 kDa.
The embodiment of the invention also provides an application of the kit or the test strip in detecting fipronil residues in a sample.
The embodiment of the invention has the following advantages:
(1) the fipronil specific binding protein provided by the invention is easy to prepare, can be specifically bound with fipronil, and has high specificity and sensitivity.
(2) The fipronil specific binding protein is applied to the fipronil detection kit and the colloidal gold detection test strip, the application operation is simple, the detection cost is low, and the fipronil in a sample can be quickly and accurately detected; and the field detection of the sample is realized.
Drawings
FIG. 1 is a standard curve diagram of a fipronil detection kit provided in example 4 of the present invention;
fig. 2 is a structural diagram of a fipronil colloidal gold test strip provided in embodiment 7 of the present invention.
In the figure: 1-sample pad; 2-gold label pad; 3-nitrocellulose membrane; 4-absorbent pad; 5-detection line; 6-quality control line; 7-PVC backing sheet.
Detailed Description
Embodiments of the present invention will be described in detail below with reference to examples, but it will be understood by those skilled in the art that the following examples are only illustrative of the present invention and should not be construed as limiting the scope of the present invention. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by manufacturers, and are all conventional products available on the market.
Example 1
The embodiment is a preparation method of a protein with an amino acid sequence shown as SEQ ID NO.1, which comprises the following steps:
obtaining a corresponding gene sequence shown as SEQ ID NO.2 through bioinformatics means screening;
carrying out PCR amplification on the gene sequence of SEQ ID NO.2, wherein the specific reaction conditions are as follows: pre-denaturation at 95 ℃ for 3 min; denaturation at 95 ℃ for 30s, annealing at 55 ℃ for 30s, extension at 72 ℃ for 1min, 30 cycles, extension for 5min, and termination at 4 ℃;
carrying out double enzyme digestion on the PCR amplification product and pET28a respectively, mixing the products after enzyme digestion, adding T4DNA ligase at 4 ℃ overnight, then transforming the ligation product into a cloning host DH5 alpha competent cell, and naming the positive recombinant plasmid as pET28a-GABA-s alpha 1, and then transforming the cloning ligation product into an expression host BL21 competent cell for expression;
taking pET28a-GABA-s alpha 1 glycerobacteria expressing GABA receptor protein out from minus 20 ℃, adding the glycerobacteria into LB culture medium according to the proportion of 1:1000 after thawing, adding antibiotics according to the proportion of 1:1000, and then culturing for 18h at 37 ℃ and 220rpm to obtain seed liquid;
transferring the seed solution according to the proportion of 1:100, adding antibiotics according to the proportion of 1:1000, adding IPTG into the culture medium after the OD value is 0.7 according to the proportion of 1:1000, inducing overnight at 18 ℃ and 180rpm, then centrifuging the bacteria induced overnight at 5000rpm for 10min, collecting precipitates, suspending the precipitates by using Buffer A, transferring the precipitates into a vessel, adding a protease inhibitor into the bacteria, uniformly mixing, carrying out ultrasonic crushing for 30min, transferring the crushed bacteria into a centrifugal tube for balancing, and centrifuging at 15000rpm for 30min at 4 ℃; wherein, the Buffer A is 50mM Hepes500mM NaCl pH7.5;
collecting the centrifuged supernatant, filtering and removing impurities through a 0.22 mu m filter, loading the filtered supernatant onto a balanced Ni column through a peristaltic pump, performing gradient elution by using an elution Buffer B, wherein the gradient elution is 0% → 10% → 100%, the elution Buffer B is 50mM Hepes500mM NaCl 500mM imidazole pH7.5, and collecting a sample at a separation peak to obtain the protein with the amino acid sequence shown in SEQ ID NO. 1.
Example 2
This example is the preparation of an elisa plate, which comprises the following steps:
diluting the protein with the amino acid sequence shown as SEQ ID NO.1 to 1 mu g/ml by using a carbonate buffer solution with the pH value of 9.6, adding 100 mu L of the protein diluent into each hole of an ELISA plate, and incubating overnight at the temperature of 4 ℃; and then, spin-drying the protein diluent, washing the plate for 3 times by using a phosphate Tween buffer solution, adding a 0.01M pH7.2PBS solution containing 1% gelatin into each hole of the ELISA plate, incubating for 2 hours at the temperature of 37 ℃, and spin-drying the confining liquid to obtain the ELISA plate.
Example 3
The embodiment is a preparation method of horseradish peroxidase-labeled fipronil hapten, which comprises the following steps:
(1) dissolving 26.86mg of fipronil hapten in 1ml of N, N-dimethylformamide solution, and diluting to 8ml by adopting PBS buffer solution;
(2) adding horseradish peroxidase 50mg into the fipronil hapten solution, and stirring until the horseradish peroxidase is fully dissolved;
(3) adding 150 mu L of 4.5% glutaraldehyde solution into the dissolved mixed solution, stirring at room temperature for 4h, then continuing stirring, dropwise adding equal volume of saturated ammonium sulfate, and reacting at 4 ℃ for 1 h;
(4) centrifuging the reacted solution at 3000r/min for 30min, collecting precipitate, washing with half-saturated ammonium sulfate for 1-3 times, dissolving the precipitate in 0.15mol/LpH7.4 PBS, dialyzing with dialysis bag with molecular weight of 10KDa, centrifuging at 10000r/min for 30min, and collecting supernatant to obtain enzyme-labeled fipronil hapten.
Example 4
The embodiment is a fipronil detection kit, which comprises a kit body, a 96-hole detachable elisa plate and a reagent, wherein the elisa plate and the reagent are arranged in the kit body and are prepared in the embodiment 2; the reagent comprises the enzyme-labeled fipronil prepared in the embodiment 3, a fipronil standard solution, a developing solution, a stop solution, a washing solution and a sample diluent;
wherein the fipronil standard solution comprises fipronil solutions with the concentrations of 0ng/ml, 0.1ng/ml, 0.3ng/ml, 0.9ng/ml, 2.7ng/ml and 8.1ng/ml respectively; the color developing solution is a single-component TMB color developing solution; the stop solution is a sulfuric acid solution with the concentration of 1M; the washing solution is 0.01M PBS solution with pH7.2 containing 0.5% Tween-20; the sample dilution was 0.1M PBS solution at pH 7.2.
Example 5
The amino acid sequence of the colloidal gold particle marker in the embodiment is SEQ ID No: 1, the preparation method comprises the following steps:
(1) 10ml of 1.5% colloidal gold solution were taken into a centrifuge tube and 100. mu.l of 0.1mol/L K were added2CO3A solution;
(2) adding 140 μ l of the protein solution prepared in example 1 with a concentration of 0.04mg/ml to the colloidal gold solution, and incubating at room temperature for 20 min; then, adding bovine serum albumin into the incubated solution to enable the final concentration of the bovine serum albumin to be 0.2% g/ml, uniformly mixing, and centrifuging at the temperature of 4 ℃ at 10000r/min for 40min to collect precipitates;
(3) re-dissolving the precipitate by using 2ml of 0.02mol/L phosphate buffer solution containing 1% of sucrose, 1% of trehalose, 2% of BSA and 0.02% of sodium azide to obtain the colloidal gold particle labeled amino acid sequence of SEQ ID No: 1.
Example 6
This example is a method for preparing fipronil antigen, which includes the following steps:
(1) 3.4972g of fipronil, 1.6g of succinic anhydride and 81ml of anhydrous pyridine are mixed and stirred uniformly;
(2) heating and refluxing the mixture for 4h, adding 60ml of ice water, adjusting the pH value to 3.0, and storing at 4 ℃ overnight;
(3) filtering the solution after the overnight, washing with ice water, filtering again, and repeating the above operation for 2-4 times to obtain fipronil hapten;
(4) 80.58mg of fipronil hapten is dissolved in 3ml of anhydrous N, N '-dimethylformamide, then 31.0mg of N, N' -dicyclohexylcarbodiimide is added into the fipronil hapten solution and stirred for 10min, after stirring is finished, 20.0mg of N-hydroxysuccinimide is added into the fipronil hapten solution and photophobic reaction is carried out for 8h at room temperature under the stirring condition;
(5) centrifuging the solution after the reaction is finished, collecting supernatant, dropwise adding the supernatant into 5ml of 10mg/ml bovine serum albumin solution prepared by 0.1mol/l phosphate buffer solution with pH8.0, and stirring overnight at 4 ℃;
(6) and (4) dialyzing and purifying the overnight product by adopting a dialysis bag with the molecular weight of 10KDa to obtain the fipronil antigen.
Example 7
The embodiment is a fipronil colloidal gold test strip, and the test strip comprises a PVC back plate 7, a nitrocellulose membrane 3, a gold-labeled pad 2, a sample pad 1 and a water absorption pad 4, wherein the amino acid sequence of the colloidal gold particle marker sprayed on the gold-labeled pad 2 prepared in the embodiment 5 is SEQ ID No: 1; the nitrocellulose membrane 3 is provided with a detection line 5 and a quality control line 6, the fipronil antigen prepared in the embodiment 6 is coated on the detection line, and a mouse anti-His tag antibody is coated on the quality control line;
wherein, the nitrocellulose membrane 3 is stuck on the PVC backboard 7; a gold mark pad 2 is stuck at the detection line 5(T line) end of the nitrocellulose membrane 3, the distance between the upper end of the gold mark pad 2 and the T line is 6mm, and the distance is overlapped with the nitrocellulose membrane 3 by 2 mm; the sample pad 1 is stuck on the gold label pad 2 and is overlapped with the gold label pad 2 by 2 mm; the end of the quality control line 6 (line C) of the nitrocellulose membrane 3 is stuck with a water absorption pad 4, and the distance between the water absorption pad 4 and the line C is 6mm and is coincided with the nitrocellulose membrane 3 by 2 mm.
Experimental example 1
The kit of embodiment 4 of the invention is adopted to detect fipronil in milk samples;
sample treatment: after shaking the milk sample uniformly, directly diluting the milk sample by using a sample diluent according to a ratio of 1: 50 to obtain a solution to be detected;
preparation of fipronil solution to be detected: dividing the solution to be detected into 4 parts, and adding fipronil into 3 parts of the solution to be detected respectively to obtain fipronil solutions to be detected, wherein the fipronil concentrations of the fipronil solutions are 0, 0.5ng/ml, 2ng/ml and 5ng/ml respectively;
the experimental method comprises the following steps:
(1) taking out the prepared ELISA plate, and standing at room temperature for 35 min;
(2) adding the standard substance and the solution to be detected of fipronil into the hole of an enzyme-labeled plate by 50 mu L per hole, and incubating for 30min at room temperature;
(3) taking out the enzyme-linked immunosorbent assay plate, washing the plate for 3 times, adding 50 mu L of enzyme-labeled fipronil, and incubating for 15min at room temperature;
(4) taking out the enzyme label plate, washing the plate for 3 times, adding 100 mu L of TMB color development solution, and incubating for 15min at room temperature;
(5) adding 50 μ L of stop solution, measuring OD value of each well at 450nm wavelength with enzyme-labeling instrument, and the measurement results are shown in Table 1;
(6) the OD value of a well containing 0ng/ml fipronil standard solution is positioned B0(ii) a Positioning the OD values of the other fipronil standard solution holes B; with B/B0Is a vertical coordinate, the logarithm C of the concentration C of the corresponding standard substance is a horizontal coordinate, and a fipronil standard curve is drawn as shown in figure 1; and the regression equation for obtaining the standard curve is that y is 0.0845x3+0.0707x2-0.4071 x + 0.3616; and the coefficient of correlation R2=0.9973。
(7) And substituting the OD value of the to-be-detected solution hole containing the fipronil into a regression equation of a standard curve to qualitatively and quantitatively determine the concentration of the fipronil in the sample, wherein the detection result is shown in a table 2.
TABLE 1
TABLE 2
Fipronil concentration (ng/ml) | Test results (ng/ml) | Recovery (%) |
0 | — | — |
0.5 | 0.461 | 92.2 |
2 | 1.754 | 87.7 |
5 | 4.819 | 96.38 |
As can be seen from tables 1 and 2: the detection sensitivity of the detection kit reaches 0.5ng/ml, and the recovery rate reaches 87.7-96.38%.
Experimental example 2
The fipronil colloidal gold test strip in the embodiment 7 is adopted to detect fipronil residues in the milk sample, and the specific operations are as follows:
sample treatment: after shaking the milk sample uniformly, directly diluting the milk sample by using a sample diluent according to a ratio of 1: 50 to obtain a solution to be detected;
preparation of fipronil solution to be detected: dividing the solution to be detected into 4 parts, and adding fipronil into 3 parts of the solution to be detected respectively to obtain fipronil solutions to be detected, wherein the fipronil concentrations of the fipronil solutions are 0, 0.5ng/ml, 2ng/ml and 5ng/ml respectively;
the experimental method comprises the following steps:
(1) preparing the prepared colloidal gold test strip and the micropore reagent, taking out and placing at room temperature for 35 min;
(2) adding 200 mu L of the solution to be detected added with the fipronil into the micropore reagent, sucking and beating the solution up and down for three times by using a pipettor, fully and uniformly mixing the solution, and standing the solution for 5min at room temperature;
(3) taking out the prepared fipronil colloidal gold test strip, inserting the sample pad end into the uniformly mixed micropore reagent solution, enabling the solution to be detected to creep towards the water absorption pad end along the sample pad end of the test strip under the siphon action, and standing for 5min at room temperature;
(4) and (3) shearing off the end of the sample pad by using scissors or sucking the residual solution to be detected on the sample pad by using absorbent paper, and judging the detection result according to the color development of the C line and the T line on the colloidal gold test strip.
When the color of the C line on the colloidal gold test strip is the same as that of the T line or is deeper than that of the T line, the result is positive; when the color of the line C is lighter than that of the line T, the result is negative; if the C line is not developed, the result is invalid and a new test strip is required for retesting.
The detection results of the four additive concentrations of the sample to be detected are shown in table 3;
TABLE 3
Fipronil concentration (ng/ml) | Test results (ng/ml) |
0 | ————— |
0.5 | ————— |
2 | ————+ |
5 | +++++ |
As can be seen from Table 3: when the adding concentration is 5ng/ml, the detection results of the fipronil colloidal gold test strip are all positive, namely the detection limit of the fipronil colloidal gold test strip on fipronil can be determined to be 5 ng/ml.
Example 3
The fipronil detection kit and the colloidal gold detection test strip of the invention have specific detection
The procedure of example 9 was followed using the fipronil colloidal gold test strip of example 7 to detect imidacloprid with a concentration of 100 μ g/ml, dieldrin with a concentration of 100 μ g/ml, chlorpyrifos with a concentration of 100 μ g/ml, endrin with a concentration of 100 μ g/ml, and cypermethrin standard solution with a concentration of 100 μ g/ml, and the detection results are shown in table 4;
TABLE 4
Medicine and concentration (mug/ml) | The result of the detection |
Imidacloprid 100 microgram/ml | ————— |
100 mug/ml dieldrin | ————— |
100 mu g/ml chlorpyrifos | ————— |
100 mug/ml endrin | ————— |
Cypermethrin 100 mug/ml | ————— |
As can be seen from Table 4, the test strip of the present invention has no significant cross reaction to the above-mentioned unrelated drugs; namely, the specificity of the protein and the fipronil adopted by the invention is good.
Finally, it should be noted that: the above embodiments are only used to illustrate the technical solution of the present invention, and not to limit the same; while the invention has been described in detail and with reference to the foregoing embodiments, it will be understood by those skilled in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; and the modifications or the substitutions do not make the essence of the corresponding technical solutions depart from the scope of the technical solutions of the embodiments of the present invention.
Sequence listing
<110> Beijing Nabai Biotechnology Ltd
<120> fipronil specific binding protein and application thereof
<130>2018
<160>2
<170>SIPOSequenceListing 1.0
<210>1
<211>195
<212>PRT
<213> Artificial (Artificial sequence)
<400>1
Met Gly Ser Ser His His His His His His Ser Ser Gly Val Arg Gly
1 5 10 15
Ser His Met Ala Ser Met Thr Gly Gly Met Gly Arg Gly Ser Val Tyr
20 25 30
Val Cys Val Val Val Ser Trp Val Ser Trp His Arg Ala Thr Ser Asp
35 40 45
Arg Val Gly Gly Thr Thr Val Thr Ser Thr Ser Asp Ser Arg Thr Asp
50 55 60
Lys Val Arg Tyr Ala Thr Ala Asp Trp Met Ser Gly Tyr Cys Ala Thr
65 70 75 80
Ala Gly Val His Tyr Thr Lys Val Gly Ser Gly Trp Asn Asn Thr Asp
85 90 95
Tyr Asp Ala Cys Ser Val Ser Cys Ser Thr Val His Thr Asp Val Ser
100 105 110
Arg Arg Arg Ser Ser Cys Asp Val Tyr Gly Val Asn Ser Val Ser Tyr
115 120 125
Arg Gly Ser Met Thr Thr Val Ser Val Thr Ser Lys Ser Thr Met Arg
130 135 140
Thr Thr Trp Lys Trp Arg Tyr Cys Ala Gly Asp Ser Arg Lys Arg Arg
145 150 155 160
Arg Ala Ala Gly Asn Cys Arg Lys Arg Gly Lys Ala Arg His Asn Ser
165 170 175
Val Ser Tyr Asp Lys Val Ala Arg Val Ala Ser Gly Asn Val Cys Tyr
180 185 190
Trp Lys Leu
195
<210>2
<211>726
<212>DNA
<213> Artificial (Artificial sequence)
<400>2
gaattcgttt acgttccgtg cgttctgatc gttgttctgt cttgggtttc tttctggatc 60
caccgtgaag ctacctctga ccgtgttggt ctgggtatca ccaccgttct gaccctgtct 120
accatctctc tggactctcg taccgacctg ccgaaagttc gttacgctac cgctctggac 180
tggttcctgc tgatgtcttt cggttactgc atcgctaccc tgctggaatt cgctggtgtt 240
cactacttca ccaaagttgg ttctggtgaa atcccgctgg aagaagaaga atgggaaaac 300
gaaaacgaaa ccgactacca ggacgctttc tgctctatcg tttcttgctc tccgcagacc 360
gttcacccgg aaaccatcat cgacgtttct cgtcgtcgtt cttctctgat ctgcgacgtt 420
tacggtgtta acgaatctgt ttcttacgaa cgtggttcta tgaccgtttc tgttacctct 480
aaaccgtcta ccatggaacg tcagacccag accgaaatct ggatcccgaa atggcgtcag 540
ttcctgtact gcctggctgg tgacgaatct ttccgtaaac gtcgtcagcg tgaagctgct 600
ggtaactgcc gtaaacgtgg tgaaaaaatc gctcgtcaca tcaactctgt ttcttacatc 660
gacaaagttg ctcgtatcgt tttcccggct tctttcggtc tgctgaacgt ttgctactgg 720
aagctt 726
Claims (8)
1. A protein specifically binding fipronil is characterized in that the protein is obtained by expression of a gene sequence shown as SEQ ID No. 2.
2. A fipronil detection kit comprises a kit body, a detachable ELISA plate and a reagent, wherein each hole of the ELISA plate is coated with the protein of claim 1; the reagent comprises enzyme-labeled fipronil, fipronil standard solution, developing solution, stop solution, washing solution and sample diluent.
3. The kit of claim 2, wherein the microplate is prepared by steps comprising:
diluting the protein to 0.5-2 mu g/ml by adopting a carbonate buffer solution, adding 50-100 mu L of the protein diluent into each hole of an enzyme label plate, and incubating overnight at the temperature of 3-5 ℃; spin-drying the protein diluent, washing the plate for 2-4 times by using a phosphate Tween buffer solution, adding a confining liquid into the ELISA plate, incubating for 1.5-2.5h at 35-39 ℃, and spin-drying the confining liquid to obtain the ELISA plate;
the blocking solution is 0.01M PBS (pH7.2) solution containing 0.05% bovine serum albumin and 5% casein or 0.01M PBS solution containing 1% gelatin and pH7.2.
4. The kit of claim 2, wherein the enzyme-labeled fipronil is a horseradish peroxidase-labeled fipronil hapten.
5. The kit according to claim 4, wherein the horseradish peroxidase-labeled fipronil hapten is prepared by the following steps:
(1) dissolving fipronil hapten in N, N-dimethylformamide solution, and diluting by adopting PBS buffer solution;
(2) adding horseradish peroxidase into the fipronil hapten solution, and fully dissolving;
(3) adding a glutaraldehyde solution into the dissolved mixed solution, stirring, and then dropwise adding saturated ammonium sulfate with the same volume under the stirring condition for reaction;
(4) and centrifuging the reacted solution, collecting precipitate, cleaning, dissolving the precipitate in a PBS solution, dialyzing by using a dialysis bag, centrifuging and collecting supernatant to obtain the enzyme-labeled fipronil hapten.
6. A fipronil colloidal gold test strip, comprising a PVC back plate, a nitrocellulose membrane, a gold-labeled pad, a sample pad and a water absorption pad, wherein the gold-labeled pad is sprayed with the colloidal gold-labeled protein of claim 1; the nitrocellulose membrane is provided with a detection line and a quality control line, the detection line is coated with a fipronil antigen, and the quality control line is coated with a mouse anti-His tag antibody.
7. The test strip of claim 6, wherein the colloidal gold-labeled protein is prepared by the steps comprising:
(1) adding K to the colloidal gold solution2CO3A solution;
(2) adding the protein solution into the colloidal gold solution for incubation; then, adding bovine serum albumin into the incubated solution, uniformly mixing, centrifuging and collecting precipitates;
(3) and re-dissolving the precipitate by using a phosphate buffer solution to obtain the protein marked by the colloidal gold particles.
8. The test strip of claim 6, wherein the fipronil antigen is prepared by the steps of:
(1) mixing fipronil, succinic anhydride and anhydrous pyridine, and stirring;
(2) heating and refluxing the mixture, adding ice water, adjusting the pH value, and storing overnight;
(3) filtering the solution after the overnight, reducing pressure, washing with ice water, and filtering to obtain fipronil hapten;
(4) dissolving fipronil hapten in anhydrous N, N '-dimethylformamide, then adding N, N' -dicyclohexylcarbodiimide into the fipronil hapten solution, stirring, adding N-hydroxysuccinimide into the fipronil hapten solution after stirring, and carrying out a light-resistant reaction at room temperature under the stirring condition;
(5) centrifuging the solution after the reaction is finished, collecting supernatant, dropwise adding the supernatant into a carrier protein solution prepared by buffer solution, and stirring overnight;
(6) and purifying the overnight product to obtain the fipronil antigen.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811341754.8A CN109293776B (en) | 2018-11-12 | 2018-11-12 | Fipronil specific binding protein and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811341754.8A CN109293776B (en) | 2018-11-12 | 2018-11-12 | Fipronil specific binding protein and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109293776A CN109293776A (en) | 2019-02-01 |
CN109293776B true CN109293776B (en) | 2020-10-16 |
Family
ID=65146635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811341754.8A Active CN109293776B (en) | 2018-11-12 | 2018-11-12 | Fipronil specific binding protein and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109293776B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110907638B (en) * | 2020-02-14 | 2020-09-22 | 北京纳百生物科技有限公司 | Antibody dispersant for immune colloidal gold homogeneous phase labeling and application thereof |
CN112111009B (en) * | 2020-07-24 | 2022-04-19 | 浙江大学 | Variable region sequence of specific anti-pyraclostrobin antibody and recombinant full-length antibody thereof |
CN117497081B (en) * | 2023-12-29 | 2024-04-05 | 北京市农林科学院 | Logic gate construction based on porphyrin COF fipronil and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101100486A (en) * | 2007-07-26 | 2008-01-09 | 浙江大学 | Fipronil artificial antigen, antibody and use thereof |
CN104971700A (en) * | 2014-04-01 | 2015-10-14 | 上海师范大学 | Affinity chromatography medium for separating and purifying GABA receptor and preparation method thereof |
CN107941785A (en) * | 2018-01-03 | 2018-04-20 | 河南省农业科学院 | A kind of surface-enhanced Raman gold label test strip for quickly detecting micro ethiprole and preparation method thereof |
CN108226490A (en) * | 2018-01-03 | 2018-06-29 | 河南省农业科学院 | A kind of quantum dot test strips for quickly detecting micro ethiprole and preparation method thereof |
-
2018
- 2018-11-12 CN CN201811341754.8A patent/CN109293776B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101100486A (en) * | 2007-07-26 | 2008-01-09 | 浙江大学 | Fipronil artificial antigen, antibody and use thereof |
CN104971700A (en) * | 2014-04-01 | 2015-10-14 | 上海师范大学 | Affinity chromatography medium for separating and purifying GABA receptor and preparation method thereof |
CN107941785A (en) * | 2018-01-03 | 2018-04-20 | 河南省农业科学院 | A kind of surface-enhanced Raman gold label test strip for quickly detecting micro ethiprole and preparation method thereof |
CN108226490A (en) * | 2018-01-03 | 2018-06-29 | 河南省农业科学院 | A kind of quantum dot test strips for quickly detecting micro ethiprole and preparation method thereof |
Non-Patent Citations (4)
Title |
---|
ACCESSION XP_026298421,cys-loop ligand-gated ion channel subunit 8916 isoform X2[Apis mellifera];Jones AK等;《Genbank》;20180919;Origin部分 * |
Fipronil ELISA Test Kit;Reagen;《Reagen》;20171113;1 * |
氟虫腈与昆虫GABA受体相互作用的研究;张元;《中国优秀硕士学位论文全文数据库》;20170215;摘要部分 * |
马铃薯甲虫(Leptinotarsa decemlineata)γ-氨基丁酸受体基因的鉴定及功能分析;傅佳;《中国优秀硕士学位论文全文数据库》;20180415;摘要部分 * |
Also Published As
Publication number | Publication date |
---|---|
CN109293776A (en) | 2019-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109293776B (en) | Fipronil specific binding protein and application thereof | |
AU2006235228B2 (en) | In vitro method for simultaneously detecting and identifying antibiotics of different classes and corresponding diagnostic kit | |
CN103172752B (en) | Mycoplasma bovis diagnosis reagent and its application | |
JP2001507792A (en) | Method for detecting IgE | |
US20080311047A1 (en) | Multimetric Biosensors and Methods of Using Same | |
Zhu et al. | Lateral flow assay for the detection of African swine fever virus antibodies using gold nanoparticle-labeled acid-treated p72 | |
EP0514173B1 (en) | Methods and compositions for enzyme complementation assays using the omega region of beta-galactosidase | |
CN111521816A (en) | Time-resolved fluorescence immunochromatographic assay test strip for echinococcosis granulosus of cattle and preparation method thereof | |
US20030104484A1 (en) | Materials and methods for detection and quantitation of an analyte | |
CN113461782B (en) | Malachite green antigen mimic epitope, preparation method and application thereof | |
CN108101968B (en) | Peste des petits ruminants vaccine strain and wild strain differential synthetic peptide and application thereof | |
JP3374101B2 (en) | Diagnosing Feline Immunodeficiency Virus Infection Using ENV / GAG Polypeptide Markers | |
CN110964089B (en) | Mycoplasma pneumoniae antigen | |
CN109642899A (en) | Use the assay for antibodies of the antigen load examination with insoluble carrier particle by different mode immobilized antigens, antibody determination reagent | |
CN110658342B (en) | Method for quantitatively detecting chloramphenicol in aquatic products through time-resolved fluorescence immunochromatography | |
CN109738639A (en) | A kind of ELISA kit detecting swine fever virus E0 protein antibodies | |
AU2009247267B2 (en) | Method for quantification of antigen-specific canine or human IgE | |
CN109490533A (en) | A kind of Pepsinogen II (PG II) detection kit and production technology | |
CN111929438B (en) | Quantum dot microsphere immunochromatography test strip for detecting African swine fever virus antibody and application thereof | |
CN108623662A (en) | Phytopathogen antigenic compound, antibody, detection kit and its application | |
CN108957002A (en) | Antibody against swine fever virus quantitative testing test paper card with double antigens sandwich and double detection lines | |
CN109336954B (en) | Beta-lactam drug receptor protein and application thereof | |
CN115166235A (en) | African swine fever virus double-antigen sandwich antibody detection kit and preparation method thereof | |
CN100519759C (en) | A process for preparation of an agglutination reagent for rapid detection of typhoid | |
KR102485291B1 (en) | Detection kit for PEDV-specific IgA comprising recombinant spike protein of PEDV |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |